![Cytodyn Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/otc/cydy.png?tr=w-200)
Cytodyn Inc
OTC:CYDY
![Cytodyn Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/otc/cydy.png)
Cytodyn Inc
Stock-Based Compensation
Cytodyn Inc
Stock-Based Compensation Peer Comparison
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/abbv.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/gild.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/amgn.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/vrtx.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/regn.png)
Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors
Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Cytodyn Inc
OTC:CYDY
|
Stock-Based Compensation
$2.2m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
![]() |
Abbvie Inc
NYSE:ABBV
|
Stock-Based Compensation
$782m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
Stock-Based Compensation
$788m
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
11%
|
![]() |
Amgen Inc
NASDAQ:AMGN
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Stock-Based Compensation
$650.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
16%
|
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cytodyn Inc's Stock-Based Compensation?
Stock-Based Compensation
2.2m
USD
Based on the financial report for Nov 30, 2023, Cytodyn Inc's Stock-Based Compensation amounts to 2.2m USD.
What is Cytodyn Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
4%
Over the last year, the Stock-Based Compensation growth was -53%. The average annual Stock-Based Compensation growth rates for Cytodyn Inc have been -44% over the past three years , and 4% over the past ten years .